Gut microbiota‐derived synbiotic formula (SIM01) as a novel

Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study - Zhang - 2022 - Journal of Gastroenterology and Hepatology - Wiley Online Library

Characterization of the Intestinal Microbiome in Healthy Adults over Sars-Cov-2 Vaccination

Frontiers Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes

Synbiotic formula shows promise in reducing long COVID symptoms

Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study - Zhang - 2022 - Journal of Gastroenterology and Hepatology - Wiley Online Library

Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19

A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial - The Lancet Infectious Diseases

The association between macronutrient intakes and coronavirus disease 2019 (COVID-19) in an Iranian population: applying a dynamical system model, Journal of Health, Population and Nutrition

2′-Fucosyllactose Promotes the Production of Short-Chain Fatty Acids and Improves Immune Function in Human-Microbiota-Associated Mice by Regulating Gut Microbiota